CDK1 and ovarian cancer: An immunohistochemical analysis of 119 human ovarian cancer samples showed that the expression of CDK1 is a prognostic factor in epithelial ovarian cancer, and knockdown of CDK1 promoted apoptosis and increased the sensitivity of epithelial ovarian cancer to chemotherapy drugs (Xi et al. 2015).